Patents Assigned to Neuralab Limited
  • Prevention and treatment of amyloidogenic disease
    Publication number: 20040081657
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.
    Type: Application
    Filed: May 2, 2003
    Publication date: April 29, 2004
    Applicants: Neuralab Limited, Athena Neurosciences, Inc.
    Inventor: Dale B. Schenk
  • Transgenic mouse assay to determine the effect of A&bgr; antibodies and A&bgr; Fragments on alzheimer's disease characteristics
    Patent number: 6710226
    Abstract: The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide, active fragments thereof or an antibody thereto.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: March 23, 2004
    Assignee: Neuralab Limited
    Inventor: Dale B. Schenk